View the LUCISOVE registration information details.
Back to drug list
ItemsDrug Registration information
ID1796
No1796
Brand NameLUCISOVE
IngredientsSOFOSBUVIR 400 MG, VELPATASVIR 100 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 28'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF ADULTS AND PEDIATRIC PATIENTS 3 YEARS OF AGE AND OLDER WITH CHRONIC HCV GENOTYPE 1,2,3,4,5 OR 6 INFECTION
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionPINK, OVAL FILM COATED TABLET WITH THE LETTER LUCIUS ON ONE SIDE AND PLAIN ON THE OTHERS
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No09 L 1226/24
FDD Registration Date31/10/2024
Expiry Date30/10/2029
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA